Clinical outcomes of FOLFIRINOX and gemcitabine–nab paclitaxel for metastatic pancreatic cancer in the real world setting
2020; Springer Science+Business Media; Volume: 23; Issue: 4 Linguagem: Inglês
10.1007/s12094-020-02473-w
ISSN1699-3055
AutoresFernando Franco, Juan Carlos Cámara, Jose Ignacio Martin-Valades, Ana López‐Alfonso, David Marrupe, David Gutiérrez-Abad, B. Martínez-Amores, Ana León, Ignacio Juez, M. Pérez, Ana Royuela, Ana Ruiz‐Casado,
Tópico(s)Renal cell carcinoma treatment
Referência(s)